Topic: Food and Drug Administration

Side effects of Adderall

There have been many deaths, some reports as high as 85, due to the use of Adderall as prescribed, these counts could be even higher due to how the death was recorded and or reported. Deaths can also be higher as a ...

Liraglutide

Liraglutide (NN2211), marketed under the brand name Victoza , is a long-acting glucagon-like peptide-1 (GLP-1) analog that has been developed by Novo Nordisk for the treatment of type 2 diabetes . Phase I trials of an oral variant of Victoza (NN9924) are ...
Around the world diabetics survive each day by injectable insulin medication: 1 When the pancreas produces (islet cells 7) little or no insulin or the cells do not respond appropriately to insulin, necessary to move glucose ( After food is eaten, broken ...

Bydureon

AMLN), Eli Lilly and Company and Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for Bydureon (exenatide extended-release for injectable suspension).. "We are committed to working ...
Biodel Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) requesting additional information regarding the company's new drug application (NDA) for Linjeta (human insulin [rDNA origin]) injection 100IU/mL for the treatment of type ...

Movie reviews: Food Inc.

Food Inc. is an entertaining, wholly informative exegesis on the nature of food production in the United States. According to this film, most cows grown for killing in this country are not built to eat corn. It makes them fatter but doesn't ...
MannKind Corporation (MNKD) Q3 2010 Earnings Conference Call October 29, 2010 9:00 am ET. (Operator Instructions) Joining us today from MannKind are Chairman and CEO, Alfred Mann; President and COO, Hakan Edstrom; Chief Financial Officer, Matthew Pfeffer; and Chief Scientific Officer, Dr. ...
This study will evaluate an investigational drug for relapsing remitting multiple sclerosis. The research site is in Sarasota, Fla.. This study, for people 18 or older, will evaluate the safety and effectiveness of two FDA approved medications to treat migraines.. The research ...
Shortly following the report, the FDA posted a warning on its website regarding the treatment.. Despite this obvious truth, the FDA accepted and promulgated the brokerage's concerns, thereby preventing many diabetes sufferers from getting the medication that could have brought them relief ...
For some time, we've been bullish on the long-term prospects of a pharmaceutical company that has made (in our opinion) a major breakthrough in medicine. Shortly following the report, the FDA posted a warning on its website regarding the treatment. Despite this ...